sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
CATX
Updated 10/6/2026, 1:28 PM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| CATX Perspective Therapeutics, Inc. | Sale | $776,947 | Lantheus Alpha Therapy, LLC 10% owner and 1 other | 247,932 sh | at $3.13 | Filed Sep 8, 4:51 PM ET | Filing | |
| CATX Perspective Therapeutics, Inc. | Sale | $131,219 | Lantheus Alpha Therapy, LLC 10% owner and 1 other | 42,129 sh | at $3.11 | Filed Sep 4, 5:00 PM ET | Filing | |
| CATX Perspective Therapeutics, Inc. | Sale | $357,184 | Lantheus Alpha Therapy, LLC 10% owner | 113,914 sh | at $3.14 | Filed Sep 4, 4:58 PM ET | Filing | |
| CATX Perspective Therapeutics, Inc. | Sale | $111,574 | Lantheus Holdings, Inc. 10% owner | 35,769 sh | at $3.12 | Filed Sep 3, 4:54 PM ET | Filing | |
| CATX Perspective Therapeutics, Inc. | Sale | $245,610 | Lantheus Holdings, Inc. 10% owner | 78,145 sh | at $3.14 | Filed Sep 2, 4:36 PM ET | Filing |